巴基斯坦HIV/AIDS患者抗逆转录病毒治疗依从性障碍与促进因素定性研究数据表

巴基斯坦HIV/AIDS患者ART依从性定性研究数据,包含25份半结构化访谈转录,分析COVID-19下的障碍与促进因素。

NIAID Data Ecosystem
浏览 15
文本people living with HIV/AIDSantiretroviralsbarriers and facilitative factorsPakistanchallengesinterventionsUNAIDSCOVID-19
DataSheet1_Barriers and Enablers for Adherence to Antiretroviral Therapy Among People Living With HIV/AIDS in the Era of COVID-19: A Qualitative Study From Pakistan.pdf

基本信息

模态
文本
大小
0.000418442 GB
许可
CC BY 4.0
创建/更新时间
2026-10-08
版本
v1

资源简介

巴基斯坦HIV/AIDS患者抗逆转录病毒治疗依从性障碍与促进因素定性研究数据表

【一句话概览】

本数据集是 figshare 公开的文本数据集,收录 1 个文件、合计 418.44 KB,主题涵盖 people living with HIV/AIDS、antiretrovirals、barriers and facilitative factors、Pakistan、challenges,可用于医学自然语言处理(实体识别、信息抽取等),CC BY 4.0 许可开放获取。

【数据集背景】

本数据集源站标题为《DataSheet1_Barriers and Enablers for Adherence to Antiretroviral Therapy Among People Living With HIV/AIDS in the Era of COVID-19: A Qualitative Study From Pakistan.pdf》。配套论文《Health-related quality of life and its predictors among adults living with HIV/AIDS and receiving antiretroviral therapy in Pakistan》发表于 Quality of Life Research(2021),DOI:10.1007/s11136-021-02771-y。源站首次发布:2022-01-28。

【数据内容】

源站原始描述:Background: With the increased availability of safe antiretroviral therapy (ART) in recent years, achieving optimal adherence and patient retention is becoming the biggest challenge for people living with HIV (PLWH). Care retention is influenced by several socioeconomic, socio-cultural, and government policies during the COVID-19 pandemic. Therefore, we aim to explore barriers and facilitators to adherence to ART among PLWH in Pakistan in general and COVID-19 pandemic related in particular. Meth…

【数据结构与技术规格】

文件数 1 个,合计 418.44 KB。DataSheet1_Barriers and Enablers for Adherence to Antiretroviral Therapy Among People Living With HIV/AIDS in the Era of COVID-19: A Qualitative Study.pdf:application/pdf,418.44 KB。数据集 DOI:10.3389/fphar.2021.807446.s001。

【主题与分类】

源站学科分类:Basic Pharmacology、Clinical Pharmacology and Therapeutics、Clinical Pharmacy and Pharmacy Practice、Pharmaceutical Sciences、Pharmacogenomics、Pharmacology。主题标签:people living with HIV/AIDS、antiretrovirals、barriers and facilitative factors、Pakistan、challenges、interventions、UNAIDS。

【适用方向】

文本类数据可用于医学自然语言处理,如命名实体识别、信息抽取与文本分类。

【获取与许可】

源站页面:https://frontiersin.figshare.com/articles/dataset/DataSheet1_Barriers_and_Enablers_for_Adherence_to_Antiretroviral_Therapy_Among_People_Living_With_HIV_AIDS_in_the_Era_of_COVID-19_A_Qualitative_Study_From_Pakistan_pdf/19085969

使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。

规范引用:Ahmed, Ali; Dujaili, Juman Abdulelah; Jabeen, Musarat; Umair, Malik Muhammad; Chuah, Lay-Hong; Hashmi, Furqan Khurshid; et al. (2022). DataSheet1_Barriers and Enablers for Adherence to Antiretroviral Therapy Among People Living With HIV/AIDS in the Era of COVID-19: A Qualitative Study From Pakistan.…

【使用注意】

· 源站最后修改于 2023-05-31,引用时请注意版本时效。

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务(收技术服务费,非数据销售)

暂未开放

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "DataSheet1_Barriers and Enablers for Adherence to Antiretroviral Therapy Among People Living With HIV/AIDS in the Era of COVID-19: A Qualitative Study.pdf" "https://ndownloader.figshare.com/files/33917618"

文件清单

  • DataSheet1_Barriers and Enablers for Adherence to Antiretroviral Therapy Among People Living With HIV/AIDS in the Era of COVID-19: A Qualitative Study.pdf(418.44 KB)

文件总体积 418.44 KB(源站 API 实测)。

数据说明

Background: With the increased availability of safe antiretroviral therapy (ART) in recent years, achieving optimal adherence and patient retention is becoming the biggest challenge for people living with HIV (PLWH). Care retention is influenced by several socioeconomic, socio-cultural, and government policies during the COVID-19 pandemic. Therefore, we aim to explore barriers and facilitators to adherence to ART among PLWH in Pakistan in general and COVID-19 pandemic related in particular.
Methods: Semi-structured interviews were conducted among 25 PLWH from December 2020 to April 2021 in the local language (Urdu) at the ART centre of Pakistan Institute of Medical Sciences, Islamabad, Pakistan. Interviews were audio-recorded in the local Urdu language, and bilingual expert (English, Urdu) transcribed verbatim, coded for themes and sub-themes, and analyzed using a phenomenological approach for thematic content analysis.
Results: Stigma and discrimination, fear of HIV disclosure, economic constraints, forgetfulness, religion (Ramadan, spiritual healing), adverse drug reactions, lack of social support, alternative therapies, and COVID-19-related lock-down and fear of lesser COVID-19 care due to HIV associated stigma were identified as barriers affecting the retention in HIV care. At the same time, positive social support, family responsibilities, use of reminders, the beneficial impact of ART, and initiation of telephone consultations, courier delivery, and long-term delivery of antiretrovirals during COVID-19 were identified as facilitators of HIV retention.
Conclusion: Improving adherence and retention is even more challenging due to COVID-19; therefore, it requires the integration of enhanced access to treatment with improved employment and social support. HIV care providers must understand these reported factors comprehensively and treat patients accordingly to ensure the continuum of HIV care. A coordinated approach including different stakeholders is required to facilitate patient retention in HIV care and consequently improve the clinical outcomes of PLWH.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.3389/fphar.2021.807446.s001(source: https://frontiersin.figshare.com/articles/dataset/DataSheet1_Barriers_and_Enablers_for_Adherence_to_Antiretroviral_Therapy_Among_People_Living_With_HIV_AIDS_in_the_Era_of_COVID-19_A_Qualitative_Study_From_Pakistan_pdf/19085969)。

数据缺失?

依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。

⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。

获取专属数据定制方案